Review
doi: 10.2174/092986712802002446.
Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT
Affiliations
- PMID: 22788764
- DOI: 10.2174/092986712802002446
Item in Clipboard
Review
Strategies to improve the killing of tumors using temozolomide: targeting the DNA repair protein MGMT
Curr Med Chem.
2012.
Abstract
Alkylating agents such as temozolomide (TMZ) are effective anticancer drugs for treating a variety of solid tumors including melanoma, glioma, and astrocytoma. TMZ exerts its effects mainly via the mutagenic product O(6)-methylguanine, a cytotoxic DNA lesion. This damage may be repaired by the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (MGMT), a key player in the resistance of cancers to TMZ. Several strategies are presently being pursued to improve the killing of tumor cells by TMZ, with inhibition of MGMT being the most promising. In this review, we provide an overview of recent advances in this field.
Similar articles
-
Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research.Mol Biol Rep. 2014 Oct;41(10):6659-65. doi: 10.1007/s11033-014-3549-z. Epub 2014 Jul 3. Mol Biol Rep. 2014. PMID: 24990698 Review.
-
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas.Cell Death Dis. 2013 Oct 24;4(10):e876. doi: 10.1038/cddis.2013.388. Cell Death Dis. 2013. PMID: 24157870 Free PMC article. Review.
-
Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen.Cell Biochem Biophys. 2012 Jan;62(1):185-91. doi: 10.1007/s12013-011-9280-7. Cell Biochem Biophys. 2012. PMID: 21892781
-
Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT.Anticancer Res. 2009 Nov;29(11):4845-54. Anticancer Res. 2009. PMID: 20032445 Review.
-
Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.Cancer Res. 2005 Apr 15;65(8):3319-27. doi: 10.1158/0008-5472.CAN-04-3335. Cancer Res. 2005. PMID: 15833865
Cited by
-
A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells in vitro.Oncol Lett. 2017 Jun;13(6):4185-4189. doi: 10.3892/ol.2017.6007. Epub 2017 Apr 7. Oncol Lett. 2017. PMID: 28599419 Free PMC article.
-
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress.Front Mol Biosci. 2021 Jan 27;7:620677. doi: 10.3389/fmolb.2020.620677. eCollection 2020. Front Mol Biosci. 2021. PMID: 33585565 Free PMC article. Review.
-
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines.Oncotarget. 2016 Jul 12;7(28):43835-43851. doi: 10.18632/oncotarget.9699. Oncotarget. 2016. PMID: 27270310 Free PMC article.
-
A peptide derived from apoptin inhibits glioma growth.Oncotarget. 2017 May 9;8(19):31119-31132. doi: 10.18632/oncotarget.16094. Oncotarget. 2017. PMID: 28415709 Free PMC article.
-
Oncolytic adenovirus-expressed RNA interference of O6-methylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide.Oncol Lett. 2014 Nov;8(5):2201-2202. doi: 10.3892/ol.2014.2442. Epub 2014 Aug 12. Oncol Lett. 2014. PMID: 25295108 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
